project id: TCGA-LUAD; case submitter id: TCGA-62-A470; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.8; normal tumor genotype snp match: Yes; age at index: 84; days to birth: -30689; days to death: 1194; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1925; year of death: 2012; age at diagnosis: 30689; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IB; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8550/3; primary diagnosis: Acinar cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; cigarettes per day: 1.643835616438356; pack years smoked: 30.0; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 1310; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-62-A470-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 4.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 95.0; percent tumor nuclei: 80.0;